SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/10/23 Chemours Co. 10-K 12/31/22 185:39M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 9.33M 2: EX-21 Subsidiaries List HTML 81K 3: EX-22 Published Report re: Matters Submitted to a Vote HTML 51K of Security Holders 4: EX-23 Consent of Expert or Counsel HTML 49K 9: EX-95 Mine-Safety Disclosure HTML 62K 5: EX-31.1 Certification -- §302 - SOA'02 HTML 54K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 54K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 50K 8: EX-32.2 Certification -- §906 - SOA'02 HTML 50K 15: R1 Document and Entity Information HTML 119K 16: R2 Consolidated Statements of Operations HTML 132K 17: R3 Consolidated Statements of Comprehensive Income HTML 162K 18: R4 Consolidated Balance Sheets HTML 186K 19: R5 Consolidated Balance Sheets (Parenthetical) HTML 60K 20: R6 Consolidated Statements of Stockholders' Equity HTML 114K 21: R7 Consolidated Statements of Stockholders' Equity HTML 51K (Parenthetical) 22: R8 Consolidated Statements of Cash Flows HTML 174K 23: R9 Background and Description of the Business HTML 62K 24: R10 Basis of Presentation HTML 53K 25: R11 Summary of Significant Accounting Policies HTML 153K 26: R12 Acquisitions and Divestitures HTML 59K 27: R13 Net Sales HTML 316K 28: R14 Research and Development Expense HTML 93K 29: R15 Restructuring, Asset-Related, and Other Charges HTML 311K 30: R16 Other Income (Expense), Net HTML 100K 31: R17 Income Taxes HTML 517K 32: R18 Earnings Per Share of Common Stock HTML 120K 33: R19 Accounts and Notes Receivable, Net HTML 111K 34: R20 Inventories HTML 87K 35: R21 Property, Plant, and Equipment, Net HTML 97K 36: R22 Leases HTML 335K 37: R23 Goodwill and Other Intangible Assets, Net HTML 200K 38: R24 Investments in Affiliates HTML 132K 39: R25 Other Assets HTML 77K 40: R26 Accounts Payable HTML 69K 41: R27 Other Accrued Liabilities HTML 90K 42: R28 Debt HTML 350K 43: R29 Other Liabilities HTML 81K 44: R30 Commitments and Contingent Liabilities HTML 484K 45: R31 Equity HTML 114K 46: R32 Stock-based Compensation HTML 365K 47: R33 Accumulated Other Comprehensive Loss HTML 132K 48: R34 Financial Instruments HTML 269K 49: R35 Long-term Employee Benefits HTML 567K 50: R36 Supplemental Cash Flow Information HTML 71K 51: R37 Geographic and Segment Information HTML 536K 52: R38 Summary of Significant Accounting Policies HTML 208K (Policies) 53: R39 Net Sales (Tables) HTML 303K 54: R40 Research and Development Expense (Tables) HTML 91K 55: R41 Restructuring, Asset-Related, and Other Charges HTML 286K (Tables) 56: R42 Other Income (Expense), Net (Tables) HTML 99K 57: R43 Income Taxes (Tables) HTML 511K 58: R44 Earnings Per Share of Common Stock (Tables) HTML 121K 59: R45 Accounts and Notes Receivable, Net (Tables) HTML 110K 60: R46 Inventories (Tables) HTML 82K 61: R47 Property, Plant, and Equipment, Net (Tables) HTML 89K 62: R48 Leases (Tables) HTML 334K 63: R49 Goodwill and Other Intangible Assets, Net (Tables) HTML 193K 64: R50 Investments in Affiliates (Tables) HTML 127K 65: R51 Other Assets (Tables) HTML 76K 66: R52 Accounts Payable (Tables) HTML 69K 67: R53 Other Accrued Liabilities (Tables) HTML 89K 68: R54 Debt (Tables) HTML 235K 69: R55 Other Liabilities (Tables) HTML 80K 70: R56 Commitments and Contingent Liabilities (Tables) HTML 265K 71: R57 Equity (Tables) HTML 94K 72: R58 Stock-based Compensation (Tables) HTML 327K 73: R59 Accumulated Other Comprehensive Loss (Tables) HTML 131K 74: R60 Financial Instruments (Tables) HTML 234K 75: R61 Long-term Employee Benefits (Tables) HTML 551K 76: R62 Supplemental Cash Flow Information (Tables) HTML 69K 77: R63 Geographic and Segment Information (Tables) HTML 528K 78: R64 Background and Description of the Business - HTML 61K Narrative (Details) 79: R65 Summary of Significant Accounting Policies - HTML 106K Narrative (Details) 80: R66 Acquisitions and Divestitures - Narrative HTML 75K (Details) 81: R67 Net Sales - Summary of Disaggregation of Net Sales HTML 118K by Geographical Region and Segment and Product Group (Details) 82: R68 Net Sales - Summary of Contract Balances from HTML 57K Contracts with Customers (Details) 83: R69 Net Sales - Narrative (Details) HTML 54K 84: R70 Net Sales - Narrative (Details1) HTML 57K 85: R71 Research and Development Expense - Summary of R&D HTML 63K Expense by Segment (Details) 86: R72 Restructuring, Asset-Related, and Other Charges - HTML 59K Schedule of Restructuring Program (Details) 87: R73 Restructuring, Asset-Related, and Other Charges - HTML 92K Schedule of Restructuring Programs to Segment (Details) 88: R74 Restructuring, Asset-Related, and Other Charges - HTML 130K Narrative (Details) 89: R75 Restructuring, Asset-Related, and Other Charges - HTML 62K Restructuring Program Schedule (Details) 90: R76 Other Income (Expense), Net - Components of Other HTML 60K Income (Expense) (Details) 91: R77 Other Income (Expense), Net - Components of Other HTML 63K Income (Expense) (Parenthetical) (Details) 92: R78 Income Taxes - Schedule of Components of Provision HTML 78K for (Benefit from) Income Taxes (Details) 93: R79 Income Taxes - Components of Deferred Tax Assets HTML 80K and Liabilities (Details) 94: R80 Income Taxes - Effective Income Tax Rate HTML 81K Reconciliation (Details) 95: R81 Income Taxes - Effective Income Tax Reconciliation HTML 81K (Details) 96: R82 Income Taxes - Summary of Income (Loss) Before HTML 59K Income Taxes (Details) 97: R83 Income Taxes - Narrative (Details) HTML 96K 98: R84 Income Taxes - Summary of open tax years by HTML 77K significant jurisdiction (Details) 99: R85 Income Taxes - Unrecognized Tax Benefits (Details) HTML 68K 100: R86 Income Taxes - Summary of Valuation Allowance HTML 57K (Details) 101: R87 Earnings Per Share of Common Stock - Schedule of HTML 83K Earnings Per Share, Basic and Diluted (Details) 102: R88 Earnings Per Share of Common Stock - Schedule of HTML 51K Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) 103: R89 Accounts and Notes Receivable, Net - Schedule of HTML 57K Accounts and Notes Receivable (Details) 104: R90 Accounts and Notes Receivable, Net - Schedule of HTML 56K Accounts and Notes Receivable (Parenthetical) (Details) 105: R91 Accounts and Notes Receivable, Net - (Narrative) HTML 51K (Details) 106: R92 Accounts and Notes Receivable, Net - Schedule of HTML 56K Allowance for Doubtful Accounts (Details) 107: R93 Accounts and Notes Receivable, Net - Schedule of HTML 53K Allowance for Doubtful Accounts (Parenthetical) (Details) 108: R94 Inventories - Schedule of Inventories (Details) HTML 61K 109: R95 Inventories - Narrative (Details) HTML 65K 110: R96 Property, Plant, and Equipment, Net - Summary of HTML 68K Property, Plant, and Equipment, Net (Details) 111: R97 Property, Plant, and Equipment, Net - Narrative HTML 55K (Details) 112: R98 Leases - Narrative (Details) HTML 54K 113: R99 Leases - Schedule of Lease Assets and Lease HTML 80K Liabilities and their Balance Sheet Locations (Details) 114: R100 Leases - Schedule of Components of Company's Lease HTML 63K Cost (Details) 115: R101 Leases - Schedule of Cash Flows Related to HTML 63K Company's Leases (Details) 116: R102 Leases - Schedule of Weighted-Average Terms and HTML 60K Weighted-Average Discount Rates For Company's Leases (Details) 117: R103 Leases - Schedule of Company's Lease Liabilities' HTML 107K Maturities For Next Five Years and Thereafter (Details) 118: R104 Leases - Build-to-suit Lease Obligation - HTML 56K Narrative (Details) 119: R105 Leases - Summary of Future Minimum Lease Payments HTML 62K Related to Chemours Discovery Hub Financing Obligation (Detail) 120: R106 Goodwill and Other Intangible Assets, Net - HTML 66K Schedule of Goodwill (Details) 121: R107 Goodwill and Other Intangible Assets, Net - HTML 88K Narrative (Details) 122: R108 Goodwill and Other Intangible Assets, Net - HTML 75K Schedule of Other Intangible Assets (Details) 123: R109 Investments in Affiliates - Narrative (Details) HTML 62K 124: R110 Investments in Affiliates - Schedule of HTML 65K Investments in Affiliates (Details) 125: R111 Investments in Affiliates - Schedule of Changes in HTML 60K Investments in Affiliates (Details) 126: R112 Other Assets - Schedule of Other Assets (Details) HTML 60K 127: R113 Accounts Payable - Schedule of Accounts Payable HTML 56K (Details) 128: R114 Other Accrued Liabilities - Schedule of Other HTML 67K Accrued Liabilities (Details) 129: R115 Debt - Components of Debt (Details) HTML 83K 130: R116 Debt - Components of Debt (Parenthetical) HTML 74K (Details) 131: R117 Debt - Senior Secured Credit Facilities - HTML 132K Narrative (Details) 132: R118 Debt - Senior Unsecured Notes - Narrative HTML 208K (Details) 133: R119 Debt - Note Repurchases - Narrative (Details) HTML 59K 134: R120 Debt - Accounts Receivable Securitization Facility HTML 78K - Narrative (Details) 135: R121 Debt - Other - Narrative (Details) HTML 54K 136: R122 Debt - Maturities and Fair Value - Narrative HTML 63K (Details) 137: R123 Debt - Schedule of Debt Principal Maturities HTML 70K (Details) 138: R124 Debt - Estimated Fair Values of Senior Debt Issues HTML 95K (Details) 139: R125 Debt - Estimated Fair Values of Senior Debt Issues HTML 72K (Parenthetical) (Details) 140: R126 Other Liabilities - Schedule of Other Liabilities HTML 60K (Details) 141: R127 Other Liabilities - Schedule of Other Liabilities HTML 50K (Parenthetical) (Details) 142: R128 Commitments and Contingent Liabilities - Summary HTML 66K of Asset Retirement Obligations (Details) 143: R129 Commitments and Contingent Liabilities - Schedule HTML 61K of Components of Accrued Litigation (Details) 144: R130 Commitments and Contingent Liabilities - Schedule HTML 58K of Components of Accrued Litigation (Parenthetical) (Details) 145: R131 Commitments and Contingent Liabilities - Schedule HTML 62K of Current and Long-term Components of Accrued Litigation and Balance Sheet Locations (Details) 146: R132 Commitments and Contingent Liabilities - Schedule HTML 56K of Current and Long-term Components of Accrued Litigation and Balance Sheet Locations (Parenthetical) (Details) 147: R133 Commitments and Contingent Liabilities - HTML 242K Litigation - Narrative (Details) 148: R134 Commitments and Contingent Liabilities - Schedule HTML 74K of Environmental Remediation Liabilities (Details) 149: R135 Commitments and Contingent Liabilities - Schedule HTML 55K of Environmental Remediation Liabilities (Parenthetical) (Details) 150: R136 Commitments and Contingent Liabilities - Schedule HTML 59K of Current and Long-term Components of Environmental Remediation Liabilities (Details) 151: R137 Commitments and Contingent Liabilities - HTML 153K Environmental - Narrative (Details) 152: R138 Commitments and Contingent - Schedule of HTML 60K Components of Accrued Environmental Remediation Liabilities Related to PFAS (Details) 153: R139 Commitments and Contingent Liabilities - Schedule HTML 63K of Current and Long-term Components of Accrued Environmental Remediation Liabilities (Details) 154: R140 Equity - Narrative (Details) HTML 82K 155: R141 Equity - Schedule of Share Repurchase Activity HTML 63K (Details) 156: R142 Stock-based Compensation - Narrative (Details) HTML 133K 157: R143 Stock-based Compensation - Weighted Average HTML 62K Assumptions of Stock Option (Details) 158: R144 Stock-based Compensation - Stock Option Activity HTML 96K (Details) 159: R145 Stock-based Compensation - Restricted Stock Units HTML 74K Activity (Details) 160: R146 Stock-based Compensation - Performance Share Units HTML 74K Activity (Details) 161: R147 Accumulated Other Comprehensive Loss - Schedule of HTML 71K Accumulated Other Comprehensive Loss (Details) 162: R148 Financial Instruments - Narrative (Details) HTML 113K 163: R149 Financial Instruments - Schedule of Derivative HTML 69K Assets and Liabilities At Fair Value (Details) 164: R150 Financial Instruments - Schedule of Pre-tax Charge HTML 75K Fair Value of Financial Instruments (Details) 165: R151 Long-term Employee Benefits (Narrative) (Details) HTML 77K 166: R152 Long-term Employee Benefits (Schedule of Net HTML 106K Periodic Pension (Cost) Income and Amounts Recognized in Other Comprehensive Income (Loss) (Details) 167: R153 Long-term Employee Benefits (Amounts Recognized in HTML 60K Accumulated Other Comprehensive Loss) (Details) 168: R154 Long-term Employee Benefits (Change in Benefit HTML 99K Obligation and Plan Assets) (Details) 169: R155 Long-term Employee Benefits (Amounts Recognized in HTML 67K Balance Sheet) (Details) 170: R156 Long-term Employee Benefits (Summary of Projected HTML 69K Benefit Obligations and Accumulated Benefit Obligations in Excess of Plan Assets) (Details) 171: R157 Long-term Employee Benefits (Assumptions) HTML 65K (Details) 172: R158 Long-term Employee Benefits (Plan Assets) HTML 102K (Details) 173: R159 Long-term Employee Benefits (Cash Flows Defined HTML 72K Benefit Plans) (Details) 174: R160 Supplemental Cash Flow information - HTML 60K Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) 175: R161 Geographic and Segment Information - Schedule of HTML 68K Net Sales and Property, Plant and Equipment, Net by Geographical Area (Details) 176: R162 Geographic and Segment Information - Narrative HTML 51K (Details) 177: R163 Geographic and Segment Information - Schedule of HTML 99K Segment Information (Details) 178: R164 Geographic and Segment Information - Summary of HTML 69K Reconciliation for Summary Financial Information for Reportable Segments (Details) 179: R165 Geographic and Segment Information - HTML 80K Reconciliation of Segment Adjusted EBITDA from Segments to Consolidated Income (Loss) Before Income Taxes (Details) 180: R166 Geographic and Segment Information - HTML 62K Reconciliation of Segment Adjusted EBITDA from Segments to Consolidated Income (Loss) Before Income Taxes (Details) (Parenthetical) (Details) 183: XML IDEA XML File -- Filing Summary XML 365K 181: XML XBRL Instance -- cc-20221231_htm XML 11.43M 182: EXCEL IDEA Workbook of Financial Reports XLSX 393K 10: EX-101.CAL XBRL Calculations -- cc-20221231_cal XML 492K 11: EX-101.DEF XBRL Definitions -- cc-20221231_def XML 2.00M 13: EX-101.LAB XBRL Labels -- cc-20221231_lab XML 3.49M 12: EX-101.PRE XBRL Presentations -- cc-20221231_pre XML 2.95M 14: EX-101.SCH XBRL Schema -- cc-20221231 XSD 545K 184: JSON XBRL Instance as JSON Data -- MetaLinks 1,018± 1.73M 185: ZIP XBRL Zipped Folder -- 0000950170-23-002467-xbrl Zip 1.21M
EX-32.1 |
Exhibit 32.1
Certification of CEO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of The Chemours Company (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Mark E. Newman, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and,
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Mark E. Newman |
|
President and Chief Executive Officer |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/10/23 | None on these Dates | ||
For Period end: | 12/31/22 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/10/24 SEC UPLOAD¶ 2/08/24 2:39K Chemours Co. 1/03/24 SEC UPLOAD¶ 2/08/24 2:42K Chemours Co. 12/13/23 SEC UPLOAD¶ 2/08/24 2:49K Chemours Co. |